Superior Prima Sukses Tbk. vs Merck Tbk. — how do they compare? Superior Prima Sukses Tbk. trades at Rp143 (market cap 1.24T, 818.7K 24h volume), while Merck Tbk. trades at Rp3,800 (market cap 1.68T, 33.3K 24h volume). The key difference: Merck Tbk. is the larger of the two by market cap, and Superior Prima Sukses Tbk. is more actively traded (818.7K versus 33.3K). Which is the better fit depends on your goals.
| BLES | MERK | |
|---|---|---|
Market Cap | 1.24T | 1.68T |
Volume | 818.7K | 33.3K |
Lot | 8.19K | 333 |
Turnover | 116.14M | 126.46M |
Average Price | 141.86 | 3,797.72 |
Value | 116.14M | 126.46M |
Indicative Equilibrium Price | 140 | 3,800 |
Indicative Equilibrium Volume | 1.2K | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT Superior Prima Sukses Tbk (the Company) was established based on Notarial Deed of Sriwati, S.H., M.Hum., No. 8 dated November 3, 2011. The Company started its operations in April 2013. PT Global Base Universal is the ultimate parent entity of the Company.
Read more on BLES →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →